Your browser doesn't support javascript.
loading
No effects of a 6-week intervention with a glucagon-like peptide-1 receptor agonist on pancreatic volume and oedema in obese men without diabetes.
Svane, Maria S; Johannesen, Helle H; Martinussen, Christoffer; Bojsen-Møller, Kirstine N; Hansen, Martin Lundsgaard; Hansen, Adam E; Deacon, Carolyn F; Hartmann, Bolette; Keller, Sune H; Klausen, Thomas L; Loft, Annika; Kjaer, Andreas; Madsbad, Sten; Löfgren, Johan; Holst, Jens J; Wewer Albrechtsen, Nicolai J.
Afiliación
  • Svane MS; Department of Endocrinology, Hvidovre Hospital, Hvidovre, Denmark.
  • Johannesen HH; Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Martinussen C; Department of Clinical Physiology, Nuclear Medicine & PET, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
  • Bojsen-Møller KN; Department of Endocrinology, Hvidovre Hospital, Hvidovre, Denmark.
  • Hansen ML; Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Hansen AE; Department of Endocrinology, Hvidovre Hospital, Hvidovre, Denmark.
  • Deacon CF; Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Hartmann B; Department of Radiology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
  • Keller SH; Department of Clinical Physiology, Nuclear Medicine & PET, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
  • Klausen TL; Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Loft A; Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Kjaer A; Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Madsbad S; Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Löfgren J; Department of Clinical Physiology, Nuclear Medicine & PET, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
  • Holst JJ; Department of Clinical Physiology, Nuclear Medicine & PET, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
  • Wewer Albrechtsen NJ; Department of Clinical Physiology, Nuclear Medicine & PET, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
Diabetes Obes Metab ; 22(10): 1837-1846, 2020 10.
Article en En | MEDLINE | ID: mdl-32495988
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 2 / Receptor del Péptido 1 Similar al Glucagón Límite: Adult / Humans / Male / Middle aged Idioma: En Revista: Diabetes Obes Metab Asunto de la revista: ENDOCRINOLOGIA / METABOLISMO Año: 2020 Tipo del documento: Article País de afiliación: Dinamarca Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 2 / Receptor del Péptido 1 Similar al Glucagón Límite: Adult / Humans / Male / Middle aged Idioma: En Revista: Diabetes Obes Metab Asunto de la revista: ENDOCRINOLOGIA / METABOLISMO Año: 2020 Tipo del documento: Article País de afiliación: Dinamarca Pais de publicación: Reino Unido